USANA HEALTH SCIENCES, INC. Business Acquisition, Pro Forma Revenue
USANA HEALTH SCIENCES, INC. (USNA) reported Business Acquisition, Pro Forma Revenue of $527.27 million for the 12-month period ending 2011-01-01, per its 10-K filed 2013-03-11.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2013-03-11
- USANA HEALTH SCIENCES, INC. business acquisition, pro forma revenue for fiscal 2011 was $527.27M.
| Period end | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|
| 2011-01-01 | $527.27M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |